Insmed (INSM) Revenue (2010 - 2026)

Insmed's Revenue history runs 12 years deep, the most recent figure standing at $306.0 million for Q1 2026.

• In Q1 2026, Revenue rose 229.62% year-over-year to $306.0 million; the TTM figure through Mar 2026 stood at $819.6 million (up 115.09% YoY), while the FY2025 annual figure was $606.4 million, up 66.73% from the prior year.
• Revenue for Q1 2026 stood at $306.0 million, up from $263.8 million in the prior quarter.
• The five-year high for Revenue was $306.0 million in Q1 2026, with the low at $53.1 million in Q1 2022.
• The 5-year median for Revenue is $83.7 million (2023), against an average of $107.5 million.
• The sharpest annual moves came in 2022 and 2026: Revenue increased 5.66% in 2022, then surged 229.62% in 2026.
• Insmed's Revenue stood at $59.3 million in 2022, then surged by 41.13% to $83.7 million in 2023, then advanced by 24.79% to $104.4 million in 2024, then jumped by 152.62% to $263.8 million in 2025, then grew by 15.96% to $306.0 million in 2026.
• Business Quant data shows INSM's Revenue at $306.0 million in Q1 2026, $263.8 million in Q4 2025, and $142.3 million in Q3 2025.